O-101 XYOTAX™/carboplatin vs paclitaxel/carboplatin for the treatmentof PS2 patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC): The stellar 3 phase III study
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 2
(8)
◽
pp. S365-S366
◽
Keyword(s):
2017 ◽
Vol 12
(1)
◽
pp. S378-S379
◽
Keyword(s):
2018 ◽
Vol 13
(4)
◽
pp. S80-S81
◽
Keyword(s):
Keyword(s):